ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » General Practice

Top General Practice Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM HOBBS M.D.

General Practice

238

$27.3K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 22%

$115
Average prescription price

Avg: $51

MATTHEW PARKER M.D.

General Practice

527

$39.7K

69
23 are 65+

29%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $51

OLUDAYO DAWODU MD

General Practice

13,124

$866K

502
356 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $51

SANDRA ALEXANDER M.D.

General Practice

5,794

$374K

350
276 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $51

ROBERT BARTEL MD

General Practice

9,565

$602K

331
138 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

46%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

THOMAS IRVING MD

General Practice

4,621

$288K

400
288 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 27%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $51

REBECCA HICKS M.D.

General Practice

2,530

$157K

80
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $51

GREGORY FUNK D.O.

General Practice

6,977

$428K

359
262 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

KEVIN DIEL MD

General Practice

7,357

$450K

390
116 are 65+

25%
patients receiving schedule two controlled substances

Avg: 7%

57%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

JERRY HANKINS MD

General Practice

906

$54.9K

233
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $51

CHARLES BUCKMASTER M.D.

General Practice

2,273

$137K

128
43 are 65+

39%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 27%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $51

MICHAEL REEVES MD

General Practice

46,350

$2.75M

904
765 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

ROBERT SCHUSTER MD

General Practice

21,019

$1.23M

1109
484 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $51

JESS YOUNGBLOOD M.D.

General Practice

27,922

$1.61M

766
298 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

41%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

MALCOLM BROWN MD

General Practice

38,182

$2.14M

965
825 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

DAVID HUBBS MD

General Practice

2,952

$165K

396
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

J HOLMES MD

General Practice

23,636

$1.3M

730
436 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

44%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

JOHN WAGNER M.D., C.M.D.

General Practice

85,781

$4.68M

1447
1273 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

36%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

FRANCES BARTEL M.D.

General Practice

3,222

$169K

111
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

ABNER LUTHER MD

General Practice

28,086

$1.44M

380
342 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

38%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

ASHLEY MCINTYRE MD

General Practice

12,067

$618K

329
208 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

PETER LITCHFIELD MD

General Practice

1,646

$84.2K

404
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 27%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

MUKESHKUMAR PATEL MD

General Practice

3,361

$168K

176
117 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 27%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

JOHN SIMMONS M.D

General Practice

23,837

$1.18M

637
458 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

JOHN KERR M.D.

General Practice

21,631

$1.06M

532
379 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 27%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank